Cargando…

The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials

BACKGROUND: Dyslipidaemia is a major risk factor for coronary heart disease (CHD). Danhong and Huangqi injections, two traditional Chinese medicine prescriptions, have been widely studied regarding their lipid-lowering properties. However, the results were inconsistent and inconclusive. Thus, we con...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Liuqin, Zhou, Chunyang, Luo, Zhi, Zeng, Wei, Lai, Feiya, Han, Gangjie, Song, Yongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944065/
https://www.ncbi.nlm.nih.gov/pubmed/29747663
http://dx.doi.org/10.1186/s12944-018-0760-2
_version_ 1783321752787484672
author Yu, Liuqin
Zhou, Chunyang
Luo, Zhi
Zeng, Wei
Lai, Feiya
Han, Gangjie
Song, Yongyan
author_facet Yu, Liuqin
Zhou, Chunyang
Luo, Zhi
Zeng, Wei
Lai, Feiya
Han, Gangjie
Song, Yongyan
author_sort Yu, Liuqin
collection PubMed
description BACKGROUND: Dyslipidaemia is a major risk factor for coronary heart disease (CHD). Danhong and Huangqi injections, two traditional Chinese medicine prescriptions, have been widely studied regarding their lipid-lowering properties. However, the results were inconsistent and inconclusive. Thus, we conducted this meta-analysis of clinical controlled trials to clarify the lipid-lowering effects of Danhong and Huangqi injections. METHODS: The databases including PubMed, Google Scholar, Web of Science, Cochrane Library, Wanfang Database, CNKI and VIP were searched. The following information was obtained from each study: first author, age, gender, ethnicity, health condition, treatment dose, treatment duration, sample size, mean and standard deviation or standard error of lipid variables before and after treatment. The changes in lipid levels from pre- to post-treatment were calculated and compared between the control groups and the treatment groups in this meta-analysis. RESULTS: Forty-four studies (5021 subjects) and 7 studies (542 subjects) were respectively identified for Danhong and Huangqi injections. Compared with the control groups, Danhong injection yielded a significant reduction in triglycerides (TG) [standardized mean difference (SMD) = − 0.76, 95% confidence interval (CI) = (− 0.91, − 0.61), P <  0.001], total cholesterol (TC) [SMD = − 1.29, 95% CI = (− 1.56, − 1.03), P <  0.001] and low-density lipoprotein cholesterol (LDL-C) [SMD = − 0.76, 95% CI = (− 0.93, − 0.59), P <  0.001], and a significant elevation in high-density lipoprotein cholesterol (HDL-C) [SMD = 0.70, 95% CI = (0.41, 0.98), P <  0.001]. Regarding Huangqi injection, it yielded a significant reduction in TC [SMD = − 1.13, 95% CI = (− 2.09, − 0.16), P = 0.02] and marginally in TG [SMD = − 1.27, 95% CI = (− 2.53, 0.00), P = 0.05] comparing with the control groups. CONCLUSIONS: Danhong injection can effectively decrease the plasma levels of TG, TC and LDL-C, and increase HDL-C levels. Huangqi injection also has significant effects on TG and TC reduction, but not as powerful as Danhong injection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12944-018-0760-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5944065
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59440652018-05-14 The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials Yu, Liuqin Zhou, Chunyang Luo, Zhi Zeng, Wei Lai, Feiya Han, Gangjie Song, Yongyan Lipids Health Dis Research BACKGROUND: Dyslipidaemia is a major risk factor for coronary heart disease (CHD). Danhong and Huangqi injections, two traditional Chinese medicine prescriptions, have been widely studied regarding their lipid-lowering properties. However, the results were inconsistent and inconclusive. Thus, we conducted this meta-analysis of clinical controlled trials to clarify the lipid-lowering effects of Danhong and Huangqi injections. METHODS: The databases including PubMed, Google Scholar, Web of Science, Cochrane Library, Wanfang Database, CNKI and VIP were searched. The following information was obtained from each study: first author, age, gender, ethnicity, health condition, treatment dose, treatment duration, sample size, mean and standard deviation or standard error of lipid variables before and after treatment. The changes in lipid levels from pre- to post-treatment were calculated and compared between the control groups and the treatment groups in this meta-analysis. RESULTS: Forty-four studies (5021 subjects) and 7 studies (542 subjects) were respectively identified for Danhong and Huangqi injections. Compared with the control groups, Danhong injection yielded a significant reduction in triglycerides (TG) [standardized mean difference (SMD) = − 0.76, 95% confidence interval (CI) = (− 0.91, − 0.61), P <  0.001], total cholesterol (TC) [SMD = − 1.29, 95% CI = (− 1.56, − 1.03), P <  0.001] and low-density lipoprotein cholesterol (LDL-C) [SMD = − 0.76, 95% CI = (− 0.93, − 0.59), P <  0.001], and a significant elevation in high-density lipoprotein cholesterol (HDL-C) [SMD = 0.70, 95% CI = (0.41, 0.98), P <  0.001]. Regarding Huangqi injection, it yielded a significant reduction in TC [SMD = − 1.13, 95% CI = (− 2.09, − 0.16), P = 0.02] and marginally in TG [SMD = − 1.27, 95% CI = (− 2.53, 0.00), P = 0.05] comparing with the control groups. CONCLUSIONS: Danhong injection can effectively decrease the plasma levels of TG, TC and LDL-C, and increase HDL-C levels. Huangqi injection also has significant effects on TG and TC reduction, but not as powerful as Danhong injection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12944-018-0760-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-10 /pmc/articles/PMC5944065/ /pubmed/29747663 http://dx.doi.org/10.1186/s12944-018-0760-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yu, Liuqin
Zhou, Chunyang
Luo, Zhi
Zeng, Wei
Lai, Feiya
Han, Gangjie
Song, Yongyan
The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials
title The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials
title_full The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials
title_fullStr The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials
title_full_unstemmed The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials
title_short The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials
title_sort lipid-lowering effects of danhong and huangqi injections: a meta-analysis of clinical controlled trials
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944065/
https://www.ncbi.nlm.nih.gov/pubmed/29747663
http://dx.doi.org/10.1186/s12944-018-0760-2
work_keys_str_mv AT yuliuqin thelipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT zhouchunyang thelipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT luozhi thelipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT zengwei thelipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT laifeiya thelipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT hangangjie thelipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT songyongyan thelipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT yuliuqin lipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT zhouchunyang lipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT luozhi lipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT zengwei lipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT laifeiya lipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT hangangjie lipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials
AT songyongyan lipidloweringeffectsofdanhongandhuangqiinjectionsametaanalysisofclinicalcontrolledtrials